They all emphasize that not only Hb levels, but also patient-related factors (e.g. age, comorbidities, risk of cardiac ischemia) and heterogeneity of anemia (acute versus chronic) should be considered in the decision to transfuse. This evidence concerns the gene GSTM1 and anemia.